Toxaphene production, in quantities similar to those of polychlorinated bip
henyls, has resulted in high toxaphene levels in fish from the Great lakes
and in Arctic marine mammals (up to 10 and 16 mu g g(-1) lipid). Because of
the large variability in total toxaphene data, few reliable conclusions ca
n be drawn about trends or geographic differences in toxaphene concentratio
ns. New developments in mass spectrometric detection using either negative
chemical ionization or electron impact modes as well as in multidimensional
gas chromatography recently have led researchers to suggest congener-speci
fic approaches. Recently, several nomenclature systems have been developed
for toxaphene compounds. Although all systems have specific advantages and
limitations, it is suggested that an international body such as the interna
tional Union of Pure and Applied Chemistry make an attempt to obtain unifor
mity in the literature. Toxicologic information on individual chlorobornane
s is scarce, bur some reports have recently appeared. Neurotoxic effects of
toxaphene exposure such as those on behavior and learning have been report
ed. Technical toxaphene and some individual congeners were found to be weak
ly estrogenic in in vitro test systems; no evidence for endocrine effects i
n vivo has been reported. in vitro studies show technical toxaphene and tox
aphene congeners to be mutagenic. However, in vivo studies have not shown g
enotoxicity; therefore, a nongenotoxic mechanism is proposed. Nevertheless,
toxaphene is believed to present a potential carcinogenic risk to humans.
Until now, only Germany has established a legal tolerance level for toxaphe
ne-0.1 mg kg(-1) wet weight for fish.